Press Releases: In-Vitro Diagnostics

Select a different year:

Siemens Enhances CentraLink Data Management System with Added Workflow and Connectivity Functions

May 21, 2012

Tarrytown, N.Y., May 21, 2012 — Siemens Healthcare Diagnostics announces enhancements to its CentraLink™ Data Management System, a proven lab process management solution that consolidates patient and quality-control data from multiple instruments and provides centralized control over critical lab processes. New functionality synchronizes automation workflow to increase efficiency and quality, as well as expands connectivity. More

Siemens Moves Critical Care Testing Closer to Patients with New Lactate Assay and Space-Saving Mobile Cart

May 18, 2012

Tarrytown, N.Y., May 18, 2012 – The FDA has cleared a lactate assay for the Siemens Healthcare Diagnostics RAPIDPoint® 500 Blood Gas System¹, giving point-of-care coordinators in the U.S. a new tool for assessing lactic acidosis. Frequently seen in critically ill patients, lactic acidosis—abnormally high acidity of the blood—has a number of potential causes, including shock, diabetes, liver disease and sepsis.²,³ More

Pleural Fluid pH Testing Now Available on Siemens Blood Gas Analyzer

May 18, 2012

Tarrytown, N.Y., May 18, 2012 – Siemens Healthcare Diagnostics received CE Mark approval to offer pleural fluid pH¹ testing on its RAPIDPoint® 500 Blood Gas System, providing laboratories and point-of-care coordinators in Europe with an important new diagnostic tool for use in critical care situations. Measuring pleural fluid pH gives clinicians information that can help guide therapy for patients. Pleural fluid effusions may be a symptom of underlying illness such as heart failure, pulmonary embolism, cancer and kidney disease.² More

Siemens Designated 2012 ‘Corporate Hometown Hero’ by American Cancer Society

May 18, 2012

Glasgow, Del., May 18, 2012 – The Glasgow, Delaware campus of Siemens Healthcare Diagnostics was presented today with a ‘Corporate Hometown Hero’ award from the American Cancer Society’s South Atlantic Division. The recognition was one of several honors presented to local community and corporate leaders who have partnered with the Society to help eliminate cancer as a major health problem. Siemens is a longstanding supporter of the Society in its mission to help fight cancer through fundraising, advocacy and education. More

Siemens Awarded New Novation Agreements for Central Laboratory Solutions

May 7, 2012

Tarrytown, N.Y., May 7, 2012 – Siemens Healthcare Diagnostics announces three new five-year agreements with Novation, LLC® for its chemistry, immunoassay, coagulation and hematology systems and assays, and automation solutions. These agreements mark the latest series of contracts between Siemens – already a long-time Novation awarded supplier – and the industry’s leading supply contracting company. Novation serves the purchasing needs of more than 65,000 members and affiliates of VHA Inc. and University HealthSystem Consortium (UHC), two national health care alliances, as well as Provista LLC. More

Siemens Receives CE Mark for New Urine Chemistry Analyzer

April 30, 2012

Tarrytown, N.Y., April 30, 2012 – Siemens Healthcare Diagnostics has received CE Mark approval to sell its CLINITEK Novus™ Automated Urine Chemistry Analyzer—the latest urine chemistry analyzer in the company’s portfolio for the central laboratory—in Europe. The CLINITEK Novus analyzer, also available in other countries, including Japan,¹ combines proven dry-pad urine chemistry technology with an easy-to-use cassette test format, helping laboratories deliver reliable, trusted test results while maximizing productivity. More

FDA Clears Siemens Fully Automated ADVIA Centaur Syphilis Assay

April 20, 2012

Tarrytown, N.Y., April 20, 2012 – Siemens Healthcare Diagnostics has received FDA clearance for its ADVIA Centaur® Syphilis Assay¹ for the detection of antibodies against Treponema pallidum, a bacterium known to cause the sexually-transmitted disease, syphilis. Now, laboratories in the United States can further automate testing for this serious condition and drive additional workflow and efficiency gains by combining it with other infectious disease testing on the Siemens ADVIA Centaur family of high-throughput, random-access immunoassay systems. More

Siemens Showcases Latest Solutions for Managing Liver Health at EASL 2012

April 18, 2012

Barcelona, Spain, April 18, 2012 – Siemens Healthcare is showcasing its broad portfolio of diagnostic solutions, designed to help physicians manage patients with liver disease, at the 47th Annual Meeting of the European Association for the Study of the Liver (EASL), Barcelona, Spain, April 18 – 22, 2012 (Booth #24). The exhibit — themed “Liver Health. Powered by Innovation.” — features the company’s most recent minimally invasive methods for assessing liver fibrosis, including the first CE-marked liver fibrosis marker panel and a new ultra-premium ultrasound platform that helps measure liver disease progression. More

Siemens Granted Three New U.S. Patents for In Vitro Methods of Diagnosing Endometriosis

April 6, 2012

Tarrytown, N.Y., April 6, 2012 – Siemens Healthcare Diagnostics was granted three new U.S. patents for methods of diagnosing endometriosis, in an effort to identify immunological markers that may be useful in development of immunodiagnostic tests to help those afflicted by this disease. More

Siemens Teams Up With the Elks and Marvel Entertainment to Help Combat Underage Drinking

April 2, 2012

Tarrytown, N.Y., April 2, 2012 – Siemens Healthcare Diagnostics has teamed up with the Elks and Marvel Entertainment, LLC to combat underage drinking and encourage families affected by substance abuse to seek help through Hard Choices. This comic book, developed by Marvel Entertainment for the Elks National Drug Awareness Program, features Spider-Man and the Fantastic Four saving young people from the consequences of alcohol abuse. This year, Hard Choices presents a public service announcement (PSA) from Siemens reminding people that “it takes the courage and strength of a warrior to ask for help.” More

Siemens Senior Clinical Consultant Wins Coveted Westgard Quality Award for Contributions in Clinical Laboratory Excellence

March 29, 2012

Antwerp, Belgium, March 29, 2012 – Jack Levine, Senior Clinical Consultant for Siemens Healthcare Diagnostics, has been named the 2012 recipient of the coveted Westgard Quality Award for his decades-long work to standardize and implement quality methods in clinical laboratories across the world. Levine was presented with the honor today during the Quality in the Spotlight international conference in Antwerp, Belgium—an annual European event devoted to the discussion of quality in laboratory medicine. More

Siemens Showcases Broad Portfolio of Infectious Disease Testing Capabilities at ECCMID 2012

March 27, 2012

London, England, March 27, 2012 – Siemens Healthcare Diagnostics is showcasing its broad portfolio of infectious disease testing capabilities¹ — from screening and diagnosis to susceptibility testing, genotyping, therapy selection and monitoring — at the 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in London, England from March 31 – April 3 (Booth #441). The Siemens solutions on display at ECCMID 2012 reinforce the company's commitment to the development of reliable, high-quality infectious disease diagnostic solutions to help laboratories optimize workflow and enhance operational efficiency. More

Siemens and ASCP Award Over 100 Scholarships to Medical Laboratory Students in 2012

March 19, 2012

Chicago and Tarrytown, N.Y., March 19, 2012 – Siemens Healthcare Diagnostics and the American Society for Clinical Pathology (ASCP) have awarded a combined $182,000 in scholarships to the nation’s top undergraduate and graduate medical laboratory students for the 2011-2012 academic year. The Siemens – ASCP Scholarship Program was established in 2003 to address the nation’s shortage of qualified medical laboratory personnel, defray education costs and promote the profession. To date, more than $1.4 million in scholarships has been awarded to qualified medical laboratory students. The 70% increase in applications over the past two years is an indicator of the continued strength of and industry need for the scholarship program. See appendix for a complete list of winners. More

Siemens Automates Education and Training-Plan Management with PEP Administrator

February 17, 2012

Tarrytown, N.Y., February 17, 2012 – Siemens Healthcare Diagnostics launches PEP¹ Administrator, an innovative web-based software solution giving clinical laboratory managers a way to simplify and streamline administration of education and training programs for their staff. PEP Administrator is an extension to Siemens’ recently launched Personalized Education Plan (PEP) – the industry’s first virtual competency-based clinical laboratory education model that can be personalized for each staff member. Designed with an intuitive interface, PEP Administrator enables education managers to guide, plan and monitor the progress of every individual learner according to her/his specific competency needs, seamlessly consolidating continuing education from any source and automatically summarizing the progress of every staff member. More

Siemens Forms New Companion Diagnostics Partnerships with ViiV Healthcare and Tocagen

February 7, 2012

Research Triangle Park, N.C., San Diego, Tarrytown, N.Y., February 7, 2012 – Siemens Healthcare Diagnostics announces two new companion diagnostics partnerships with pharmaceutical companies ViiV Healthcare and Tocagen — marking a major step for Siemens into this important and fast-growing segment of the in vitro diagnostics (IVD) market. Both partnerships intend to leverage the clinical trial and commercialization options within Siemens’ CLIA laboratory, as well as Siemens’ established IVD clinical and regulatory expertise. More

Siemens Automated Mycophenolic Acid Test on Dimension Systems Now Available in U.S.

February 3, 2012

Tarrytown, NY., February 3, 2012 – The Siemens Healthcare Diagnostics Mycophenolic Acid assay (MPAT) is now available for use on the company’s portfolio of Dimension® Integrated Chemistry Systems in the U.S. With this addition, the company becomes the first laboratory diagnostics solutions provider in the nation to offer the consolidation of four fully automated immunosuppressant drug (ISD) assays on a single integrated chemistry system. The four ISD tests—mycophenolic acid, cyclosporine, tacrolimus and sirolimus—are the most commonly prescribed immunosuppressants used by physicians to prevent organ rejection. Now, they can be run simultaneously with routine chemistry tests on the Dimension systems, enabling more comprehensive care for transplant patients. More

Siemens Adds New VERSANT kPCR HCV Assay to Menu of Diagnostic Solutions for Liver Disease Management

January 6, 2012

Tarrytown, N.Y., January 6, 2012 – The Siemens Healthcare Diagnostics VERSANT® HCV RNA 1.0 Assay is now CE-marked for use on the company’s VERSANT kPCR Molecular System, giving laboratories in Europe and Australia access to a new test to aid in the management of individuals infected with hepatitis C (HCV) who are undergoing antiviral therapy. 1,2 This new, highly sensitive automated viral load assay is an important addition to the company’s portfolio of diagnostic solutions for managing patients with liver disease, which includes routine chemistry tests, hepatitis serology tests, viral load testing and ultrasound systems. More